Recent Finacing
Recent Raise
NeuroTherapeutics Pharma develops mechanism-specific small molecules (lead NTP-2014) for CNS disorders including epilepsy, pain, and other neurological indications, advancing a pipeline toward Phase II trials.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors